Childhood Vaccines: The Complete US Immunization Schedule Every Parent Needs to Know

The Centers for Disease Control and Prevention childhood immunization schedule is one of the most evidence-reviewed documents in all of medicine. Updated annually by the Advisory Committee on Immunization Practices (ACIP) — a group of independent experts in infectious disease, pediatrics, epidemiology, and public health — it recommends vaccines for 16 preventable diseases from birth through age 18. The schedule is not arbitrary. Each timing recommendation is based on when immunity is most needed (when disease risk is highest or when maternal antibodies wane), when the immune system mounts the most effective response, and how to achieve protection as early as possible while ensuring safety. For parents navigating an enormous amount of conflicting information, understanding the actual evidence — and what diseases these vaccines prevent — is both empowering and clarifying.

Vaccines From Birth Through 6 Years: What the Schedule Looks Like

Birth

Hepatitis B (HepB) — dose 1. Hepatitis B virus (HBV) can be transmitted from mother to infant during delivery, even from mothers who do not know they are infected. Vertical transmission at birth carries a 90% risk of chronic infection if untreated — and chronic HBV leads to cirrhosis and liver cancer decades later. The first dose within 24 hours of birth interrupts this transmission pathway. This timing is not aggressive; it is precisely calibrated to the moment of maximum exposure risk.

2 Months

The 2-month visit is the most vaccine-intensive of the schedule: DTaP (diphtheria, tetanus, acellular pertussis), Hib (Haemophilus influenzae type b), IPV (inactivated poliovirus), PCV15 or PCV20 (pneumococcal conjugate), and RV (rotavirus oral vaccine). This cluster of vaccines reflects the window at which maternal antibody protection is waning and the infant becomes vulnerable. Multiple vaccines at the same visit have been extensively studied — the immune system of an infant can handle many antigens simultaneously, and coadministration does not weaken immune responses. Infants are exposed to far more antigens daily from their environment than from any vaccine schedule.

4 and 6 Months

Second and third doses of DTaP, Hib, IPV, PCV, and RV. These boosters are essential for building durable immunity — a single dose produces initial antibody, but subsequent doses are required to reach protective threshold levels and establish immunologic memory. Hepatitis B dose 2 is given at 1–2 months and dose 3 at 6–18 months.

12–15 Months

MMR (measles, mumps, rubella) — dose 1. Given at 12–15 months because maternal antibodies to measles, transferred during pregnancy, interfere with vaccine response if given earlier. Measles is one of the most contagious diseases known — infectious from 4 days before to 4 days after the rash appears, spreading through airborne droplets that can remain viable in enclosed air for up to 2 hours after an infected person has left the room. Before the vaccine (introduced in 1963), measles infected virtually every American child, hospitalizing 48,000 and killing 400–500 annually. Varicella (chickenpox) — dose 1. Chickenpox causes over 4 million cases, 10,000 hospitalizations, and 100–150 deaths annually in pre-vaccine eras; vaccination has reduced cases by over 90%.

15–18 Months and 4–6 Years

DTaP and IPV boosters. MMR and varicella dose 2 at 4–6 years. The second MMR dose is not for initial protection — it catches the approximately 5% of individuals who do not respond fully to the first dose, ensuring close to 97% population protection.

Vaccines During the School Years: Ages 7–12

Influenza vaccine annually from 6 months onward. Influenza kills 3,000–50,000 Americans per year depending on the season and circulating strain. Vaccination reduces hospitalization rates, transmission in households, and the risk of severe complications. Annual revaccination is necessary because influenza viruses mutate, and vaccine composition is updated each year to match circulating strains.

Between ages 7 and 10, catch-up vaccines may be administered for children who missed earlier doses. This is common and straightforward — catch-up schedules are published by the CDC and maintain the same protective outcomes.

Vaccines at 11–12 Years

Tdap: A booster for tetanus, diphtheria, and pertussis. Immunity from childhood DTaP wanes over approximately 10 years, necessitating this adolescent booster. Pertussis (whooping cough) has resurged in recent decades, with outbreaks sickening and killing infants too young to be fully vaccinated — immunizing older children and adults reduces transmission to vulnerable infants (cocooning strategy).

HPV vaccine (human papillomavirus): Protects against the 9 HPV types (Gardasil-9) responsible for approximately 90% of cervical cancers, 70% of oropharyngeal cancers, most anal cancers, and genital warts. Given at age 11–12 because vaccine response is stronger when given before potential HPV exposure, and a 2-dose series (rather than 3) suffices if the first dose is given before age 15. HPV vaccines have been administered to hundreds of millions of people globally and have dramatically reduced cervical dysplasia rates in vaccinated cohorts — with data from countries with high uptake showing up to 90% reductions in CIN2+ (precancerous cervical lesions) in young women. This is a cancer prevention vaccine.

MenACWY (meningococcal conjugate vaccine): Protects against meningococcal disease caused by serogroups A, C, W, and Y. Meningococcal meningitis can progress from headache to death in under 24 hours; survivors frequently experience amputation, hearing loss, or neurological damage. College freshmen living in dormitories face elevated risk, driving the requirement for a booster dose at 16 years.

Vaccines at 16 Years

MenACWY booster and, recommended since 2023, MenB (serogroup B meningococcal vaccine) for adolescents at increased risk or by individual preference.

COVID-19 and RSV Vaccines

Updated COVID-19 vaccines are recommended annually for all individuals 6 months and older, with the current mRNA vaccine compositions updated to match circulating variants. Severe COVID-19, MIS-C (multisystem inflammatory syndrome in children), and long COVID are real risks in unvaccinated children, and vaccination substantially reduces these outcomes.

Addressing Safety Concerns Honestly

Vaccines and Autism

The claim that vaccines cause autism originated from a 1998 Lancet paper by Andrew Wakefield that was subsequently found to have fraudulently manipulated data. The paper was retracted in 2010, and Wakefield lost his medical license. Every subsequent large, well-conducted study — including a Danish cohort study of 657,461 children (Hviid et al., 2019) and a 2020 meta-analysis involving more than 1.2 million children — has found no association between any vaccine, individually or in combination, and autism spectrum disorder. The specific MMR vaccine, the thimerosal preservative (removed from childhood vaccines in 2001 except multidose influenza vials, and never proven harmful at vaccine doses), and the cumulative vaccine schedule have all been comprehensively studied. The scientific consensus is unambiguous. Autism symptoms often become more apparent to parents around 12–18 months — the same time the MMR is given — which creates a temporal association that is coincidental, not causal. ASD has prenatal origins that precede any vaccination.

Can Vaccines Overwhelm the Immune System?

This is a physiologically implausible concern. A healthy infant's immune system can theoretically respond to millions of antigens simultaneously. The current childhood vaccine schedule contains far fewer antigens than the vaccines of 40 years ago, despite protecting against more diseases — because modern vaccines are more refined and targeted. Receiving multiple vaccines at one visit does not deplete immune capacity or increase susceptibility to infections.

Common Reactions and What to Expect

Common vaccine reactions include soreness at the injection site (lasting 1–2 days), low-grade fever (particularly after DTaP and MMR), and fussiness or fatigue. These are signs of immune activation — the immune system mounting the response the vaccine is designed to trigger. Serious adverse reactions (severe allergic reactions, anaphylaxis) occur in approximately 1 to 2 per million doses. Every vaccination site is equipped to manage anaphylaxis. The benefit-risk ratio of every vaccine on the schedule strongly favors vaccination.

Herd Immunity: Why Your Child's Vaccination Protects Others

Herd immunity (community immunity) occurs when a sufficient proportion of a population is immune to a disease — through vaccination or prior infection — to interrupt ongoing transmission and protect those who cannot be vaccinated. For measles, which is among the most contagious diseases known (R0 of 12–18), herd immunity requires approximately 95% of the population to be immune. For pertussis, approximately 92–94%. When vaccination rates fall below these thresholds, outbreaks occur and affect not just the unvaccinated but also immunocompromised individuals who cannot receive vaccines, newborns too young for vaccination, and the small percentage of vaccinated people who do not develop full immunity. This is why vaccination is a public health act as well as a personal one.

School Requirements by State

All 50 US states and the District of Columbia require proof of vaccination for school entry, though specific vaccines required and exemption policies vary. Most states require DTaP, MMR, varicella, polio, and hepatitis B for kindergarten entry. HPV and hepatitis A requirements vary by state. All states allow medical exemptions for documented contraindications (such as true vaccine allergy or immunocompromising conditions). Religious and philosophical exemptions are allowed in most but not all states. Children with unvaccinated status may be excluded from school during outbreak periods even with exemptions.

What to Do If Your Child Is Behind on Vaccines

Catching up is straightforward and common. The CDC publishes official catch-up immunization schedules that specify the minimum intervals required between doses for each vaccine, regardless of age or how long since the previous dose. A child who missed vaccines at earlier ages can complete the schedule on a condensed timeline without needing to start over. Your pediatrician or family physician can create a catch-up plan in a single office visit, or you can use the CDC's online immunization schedule manager at cdc.gov/vaccines.

When to See a Doctor

Talk to your child's physician before vaccination if your child has a known severe allergy to any vaccine component (such as gelatin or neomycin), has had a serious reaction to a previous dose, or has a condition that weakens the immune system — some vaccines require modification or precautions in these situations. If your child has fallen behind on vaccines and you are unsure where to start, any JourneyDoctors trained physician can review your child's vaccine history and provide guidance. JourneyDoctors connects you with trained specialists from $19. Start a consultation today — no waiting room, no referral needed.

This article is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional for diagnosis and treatment.

Frequently Asked Questions

Why does my baby need so many vaccines so early?

Infants are most vulnerable to many vaccine-preventable diseases in the first year of life, when their immune systems are immature and maternal antibody protection is waning. Diseases like Hib meningitis, pertussis, and pneumococcal disease kill and disable most commonly in the first months of life. The schedule is front-loaded precisely because protection is needed earliest. Delaying vaccination to a "modified schedule" leaves infants unprotected during their highest-risk window.

Can I spread out the vaccines to reduce the burden on my baby?

Alternative or delayed vaccine schedules — such as the Sears "Selective Schedule" — have no scientific basis and have not been demonstrated safer than the CDC schedule. They guarantee extended periods of vulnerability, require more total doctor's visits, and create incomplete protection at the ages when it is most needed. The AAP, AAFP, and CDC do not recommend modified schedules and have reviewed the evidence for doing so. The standard schedule has been evaluated in hundreds of millions of children and is demonstrably safe.

Are there ingredients in vaccines I should be concerned about?

Vaccine ingredients are scrutinized more thoroughly than perhaps any other pharmaceutical components. Aluminum salts (adjuvants) — present in some vaccines to enhance immune response — are present in amounts that are physiologically trivial relative to daily aluminum intake from food and breast milk. Formaldehyde is used in some vaccine manufacturing processes; residual amounts are far lower than what the body produces endogenously. Thimerosal, an ethylmercury-based preservative, was removed from routine childhood vaccines (except some multi-dose flu vials) by 2001 and was never demonstrated harmful at vaccine doses. Regulatory agencies review each ingredient and its safety profile extensively before licensure.

My child had a high fever after vaccination — is that dangerous?

Post-vaccine fever, typically low-grade (100–101°F, occasionally higher), is a normal immune response, not an adverse event. It usually appears within 24 hours, resolves within 1–2 days, and can be managed with acetaminophen or ibuprofen (ibuprofen only in children 6 months and older). A fever above 104°F, a fever lasting more than 3 days, a seizure (febrile seizures are rare but can occur with any fever), or any signs of serious illness should prompt medical evaluation. Report serious post-vaccine reactions to your physician and to the Vaccine Adverse Event Reporting System (VAERS).

Is the flu shot really necessary every year?

Yes. Influenza viruses mutate rapidly through antigenic drift and shift, meaning the strains circulating in any given season are significantly different from the prior year. Annual vaccine reformulation — based on WHO surveillance of circulating strains — is necessary to maintain effectiveness. Influenza kills tens of thousands of Americans annually and hospitalizes hundreds of thousands more. Children under 5, particularly under 2, are at especially high risk of complications. Annual influenza vaccination of children is one of the highest-return public health interventions available.